학술논문
Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Document Type
Article
Author
Source
In: Bone Marrow Transplantation . (Bone Marrow Transplantation, April 2023, 58(4):401-406)
Subject
Language
English
ISSN
14765365
02683369
02683369